Latest News
|
7 November 2012
0 Likes
The US Food and Drug Administration (FDA) plans to hold a meeting on the regulatory science issues surrounding the development of antibiotics to treat Burkholderia pseudomallei —a dangerous
Read More...
Latest News
|
5 April 2012
0 Likes
The US Food and Drug Administration (FDA) is announcing the launch of a new program that it hopes will help to advance clinical trial design and endpoints to boost regulatory science and facilitate
Read More...